Hyderabad: Sanofi Pasteur, the vaccines division of Sanofi, announced today that its affiliate Shantha Biotechnics has delivered the first 400,000 doses of the paediatric Pentavalent vaccine, Shan5 to support the immunisation of children in Gwalior and Jabalpur in Madhya Pradesh.
In December 2014, following a two-year international tender, Shantha was awarded to supply global health organisations with a total of 37 million doses of Shan5 in 2015 and 2016, in a ten-dose vial presentation, a company statement said.
"This tender provides the basis upon which purchase orders will be made for specific vaccine deliveries throughout the period, depending on country needs," it said.
The Shan5 vaccine will be used in the routine immunisation programmes of a number of countries, supported by Gavi, a global vaccine alliance, enabling up to ten million children to receive protection from five paediatric diseases, the company said.
